RecruitingNCT05361603

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Structures

Acceptability of Simultaneous Screening for Viral Hepatitis B, C and HIV Among Drug Users in Non-conventional Facilities "Outside the Walls" Using the Dual Screening Method TROD (Rapid Diagnostic Tests) and FibroScan

Sponsor

University Hospital, Limoges

Enrollment

1,500 participants

Start Date

May 24, 2017

Study Type

OBSERVATIONAL

Conditions

Hepatitis C Transmission, Intravenous Drug Abuser Addiction, Alcohol Addiction Opiate Hepatitis C Virus Infection, Response to Therapy of

Summary

The principle is to propose dedicated monthly screening days bringing together the health personnel involved (hepatologist, addictologist, nurse in charge of the program, addictology nurse and social worker) and to propose appropriate management for each situation assessed.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study in France is examining whether offering simultaneous testing for hepatitis B, hepatitis C, and HIV at non-traditional community settings (outside of hospitals and clinics) is acceptable and practical for people who use drugs. **You may be eligible if...** - You are 18 or older - You use drugs and access services at a community outreach or non-traditional health setting - You agree to participate in the research **You may NOT be eligible if...** - You do not consent to participate in the research Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.